A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children with Achondroplasia, Age 0 to < 60 Months (111-206)

Project: Research project

Project Details

StatusActive
Effective start/end date9/26/18 → 8/31/50

Funding

  • BioMarin Pharmaceutical Inc.